Quadrant Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.3M Buy
78,756
+1,322
+2% +$308K 0.58% 25
2025
Q4
$16M Buy
77,434
+2,125
+3% +$420K 0.48% 25
2025
Q3
$14M Buy
75,309
+9,966
+15% +$1.71M 0.45% 27
2025
Q2
$9.98M Buy
65,343
+13,774
+27% +$2.12M 0.36% 36
2025
Q1
$8.55M Buy
51,569
+29,274
+131% +$4.58M 0.32% 38
2024
Q4
$3.22M Sell
22,295
-3,110
-12% -$482K 0.22% 52
2024
Q3
$4.12M Buy
25,405
+190
+0.8% +$30.3K 0.29% 43
2024
Q2
$3.69M Sell
25,215
-898
-3% -$134K 0.27% 47
2024
Q1
$4.13M Sell
26,113
-1,849
-7% -$294K 0.33% 42
2023
Q4
$4.38M Sell
27,962
-1,257
-4% -$193K 0.38% 39
2023
Q3
$4.55M Sell
29,219
-426
-1% -$70.3K 0.46% 32
2023
Q2
$4.91M Buy
29,645
+4,298
+17% +$694K 0.49% 30
2023
Q1
$3.93M Sell
25,347
-5,110
-17% -$825K 0.41% 35
2022
Q4
$5.38M Buy
30,457
+4,039
+15% +$697K 0.61% 25
2022
Q3
$4.32M Sell
26,418
-303
-1% -$51.3K 0.57% 26
2022
Q2
$4.74M Buy
26,721
+934
+4% +$166K 0.64% 27
2022
Q1
$4.57M Buy
25,787
+1,211
+5% +$206K 0.55% 30
2021
Q4
$4.2M Buy
24,576
+3,367
+16% +$551K 0.5% 37
2021
Q3
$3.42M Buy
21,209
+1,531
+8% +$261K 0.48% 38
2021
Q2
$3.24M Buy
19,678
+1,190
+6% +$197K 0.47% 36
2021
Q1
$3.04M Buy
18,488
+1,912
+12% +$309K 0.49% 34
2020
Q4
$2.61M Sell
16,576
-83
-0.5% -$12.2K 0.48% 32
2020
Q3
$2.48M Sell
16,659
-235
-1% -$34.8K 0.54% 30
2020
Q2
$2.38M Sell
16,894
-7,979
-32% -$1.16M 0.53% 32
2020
Q1
$3.26M Buy
24,873
+1,741
+8% +$247K 0.55% 30
2019
Q4
$3.34M Buy
23,132
+3,814
+20% +$517K 0.4% 37
2019
Q3
$2.48M Sell
19,318
-2,418
-11% -$319K 0.38% 42
2019
Q2
$3M Buy
21,736
+2,740
+14% +$379K 0.48% 34
2019
Q1
$2.63M Buy
18,996
+2,445
+15% +$328K 0.46% 36
2018
Q4
$2.12M Buy
16,551
+220
+1% +$30.7K 0.56% 29
2018
Q3
$2.24M Sell
16,331
-546
-3% -$72.6K 0.64% 27
2018
Q2
$2.02M Buy
16,877
+323
+2% +$40.3K 0.71% 24
2018
Q1
$2.1M Buy
16,554
+3,176
+24% +$429K 0.76% 24
2017
Q4
$1.85M Buy
13,378
+473
+4% +$65.9K 0.74% 24
2017
Q3
$1.66M Sell
12,905
-11
-0.1% -$1.46K 0.68% 25
2017
Q2
$1.63M Sell
12,916
-324
-2% -$41.3K 0.72% 23
2017
Q1
$1.63M Buy
13,240
+1,679
+15% +$201K 0.72% 23
2016
Q4
$1.32M Sell
11,561
-284
-2% -$32.8K 0.66% 29
2016
Q3
$1.38M Buy
11,845
+1,117
+10% +$136K 0.9% 16
2016
Q2
$1.29M Sell
10,728
-929
-8% -$106K 0.89% 18
2016
Q1
$1.25M Buy
11,657
+923
+9% +$95.6K 0.81% 22
2015
Q4
$1.09M Sell
10,734
-1,588
-13% -$160K 0.76% 21
2015
Q3
$1.14M Buy
12,322
+749
+6% +$72.5K 0.79% 20
2015
Q2
$1.12M Buy
+11,573
New +$1.16M 0.71% 23

Other funds holding JNJ

Quadrant Capital Group's JNJ Position: Q1 2026 in Review

Quadrant Capital Group increased its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2026, buying an estimated $308K and bringing the position to 78,756 shares worth $19.3M. The position accounts for 0.58% of the portfolio, ranked #25.

Quadrant Capital Group first reported a position in JNJ in Q2 2015 and has held it in 44 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Quadrant Capital Group held 78,756 shares of Johnson & Johnson worth $19.3M as of Q1 2026.
  • Quadrant Capital Group bought 1,322 Johnson & Johnson shares in Q1 2026, an estimated $308K.
  • Johnson & Johnson made up 0.58% of Quadrant Capital Group's portfolio in Q1 2026, its #25 holding.
  • Quadrant Capital Group first reported a position in Johnson & Johnson in Q2 2015 and has held it in 44 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.